Singapore cancer network (SCAN) guidelines for the use of systemic therapy in advanced non-small cell lung cancer

The Singapore Cancer Network (SCAN) Lung Cancer Workgroup

Research output: Contribution to journalArticle

Abstract

Introduction: The SCAN lung cancer workgroup aimed to develop Singapore Cancer Network (SCAN) clinical practice guidelines for the use of systemic therapy in advanced non-small cell lung cancer (NSCLC) in Singapore. Materials and Methods: The workgroup utilised a modifi ed ADAPTE process to calibrate high quality international evidence-based clinical practice guidelines to our local setting. Results: Five international guidelines were evaluated-those developed by the National Comprehensive Cancer Network (2014), the European Society of Medical Oncology (2014), the National Institute of Clinical Excellence (2012), the Scottish Intercollegiate Guidelines Network (2014) and Cancer Care Council Australia (2012). Recommendations on systemic treatment for advanced NSCLC were produced. Conclusion: These adapted guidelines form the SCAN guidelines 2015 for systemic therapy of advanced or metastatic NSCLC.

Original languageEnglish (US)
Pages (from-to)449-462
Number of pages14
JournalAnnals of the Academy of Medicine Singapore
Volume44
Issue number10
StatePublished - Oct 2015

Keywords

  • ADAPTE process
  • Asian population
  • Chemotherapy
  • Targeted therapy

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Singapore cancer network (SCAN) guidelines for the use of systemic therapy in advanced non-small cell lung cancer'. Together they form a unique fingerprint.

  • Cite this